Panacea Life Sciences Holdings, Inc. Announces Participation in Investor Summit Group’s Q2 In-Person Conference
GOLDEN, CO / ACCESSWIRE / May 3, 2022 / Panacea Life Sciences Holdings, Inc. (OTCQB:PLSH) is pleased to announce that...
GOLDEN, CO / ACCESSWIRE / May 3, 2022 / Panacea Life Sciences Holdings, Inc. (OTCQB:PLSH) is pleased to announce that...
STOCKHOLM, SE / ACCESSWIRE / May 03, 2022 / Vimian Group (STO:VIMIAN)Vimian Group AB (publ) ("Vimian"), Reg. No. 559234-8923, with...
Conference Call/Webcast Tomorrow (Tuesday, May 3) at 5 pm ET TORONTO & DALLAS--(BUSINESS WIRE)--Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC)...
ATLANTA--(BUSINESS WIRE)--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced preliminary unaudited fiscal...
MOBILE, Ala.--(BUSINESS WIRE)--$CPSI--CPSI (NASDAQ: CPSI), a healthcare solutions company (“CPSI” or the “Company”), today announced that Boyd Douglas will retire...
KORU expands label indication for self-administered FreedomEdge infusion system CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ:...
RANCHO CUCAMONGA, CA / ACCESSWIRE / May 2, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release...
BALTIMORE, MD / ACCESSWIRE / May 2, 2022 / Univec, Inc. (OTCMarktets:UNVC) a mental health and substance abuse total wraparound...
KITCHENER, ON / ACCESSWIRE / May 2, 2022 / Cloud DX (TSXV:CDX) (OTCQB:CDXFF), (the "Company") a leading North American provider...
Need an expert commentator on grief, trauma and burnout?Meet Sherry Walling, MAT, PhDMINNEAPOLIS, MN / ACCESSWIRE / May 2, 2022...
WHITE PLAINS, NY / ACCESSWIRE / May 2, 2022 / Hospice of Westchester (HOW) has voted in new officers and...
Collaboration with HealCommunity Offers Remote Access to Reimbursable Group Therapy OptionTORONTO, ON / ACCESSWIRE / May 2, 2022 / Novamind...
LAS VEGAS, NV / ACCESSWIRE / May 2, 2022 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNHF) ("Planet 13" or the "Company"),a...
– Experienced oncology drug developer with more than two decades advancing treatments for solid tumors and hematologic malignancies joins Codiak leadership...
CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., May 02, 2022 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company...
The Phase I safety and pharmacokinetic study in 24 healthy volunteers has completed enrollment. The study is still blinded, but...
HPN328, Harpoon’s DLL3-targeting T cell engager, to be evaluated in combination with anti-PD-L1 antibody in patients with small cell lung...
LAS VEGAS, NV, May 02, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Digipath, Inc. (OTCQB: DIGP) (“Digipath” or the “Company”),...
Beverly Hills, May 02, 2022 (GLOBE NEWSWIRE) -- While studying for her Doctor of Dental Surgery degree at the University...
Company to host conference call and webcast at 5:00 p.m. ETMENLO PARK, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- CohBar,...